Burden and health care resource utilization in neovascular age-related macular degeneration -: Findings of a multicountry study

被引:117
作者
Soubrane, Gisele
Cruess, Alan
Lotery, Andrew
Pauleikhoff, Daniel
Mones, Jordi
Xu, Xiao
Zlateva, Gergana
Buggage, Ronald
Conlon, John
Goss, Thomas F.
机构
[1] Univ Paris 12, Dept Ophthalmol, Ctr Hosp Intercommunal, Creteil, France
[2] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS, Canada
[3] Univ Southampton, Div Clin Neurosci, Southampton, Hants, England
[4] St Franziskus Hosp, Dept Ophthalmol, Munster, Germany
[5] Inst Microcirugia Ocular Barcelona, Barcelona, Spain
[6] Covance Market Access Serv Inc, Gaithersburg, MD USA
[7] Pfizer Ophthalm, New York, NY USA
[8] Covance Inc, Princeton, NJ USA
关键词
D O I
10.1001/archopht.125.9.1249
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To describe the burden of bilateral neovascular age-related macular degeneration (NV-AMD) on patient-reported functioning and health resource utilization. Methods: A cross-sectional study of 401 patients with bilateral NV-AMD and 471 elderly control subjects without AMD was conducted in 5 countries. Subjects completed a telephone survey, including the National Eye Institute 25-Item Visual Function Questionnaire, the EuroQol instrument, the Hospital Anxiety and Depression Scale, and history of falls, fractures, and health care resource utilization. Results: The mean age for patients with NV-AMD was 78.1 years, and 65% were women. The patients reported 45% worse vision-related functioning, 13% worse overall wellbeing, and 30% more anxiety and 42% more depression symptoms than controls after adjusting for covariates (all, P <. 001). The effect of NV-AMD was also observed as a doubled fall rate (16% vs 8% [P <. 001]) and a quadrupled need for assistance with daily activities (29% vs 7% [P <. 001]) in the patients compared with controls. Conclusions: The evidence of extensive decline in quality of life and increased need of daily living assistance for patients with NV-AMD compared with a control population substantiates the need for new treatments that prevent vision loss and progression to blindness.
引用
收藏
页码:1249 / 1254
页数:6
相关论文
共 28 条
[1]   Age-related macular degeneration: Etiology, pathogenesis, and therapeutic strategies [J].
Ambati, J ;
Ambati, BK ;
Yoo, SH ;
Ianchulev, S ;
Adamis, AP .
SURVEY OF OPHTHALMOLOGY, 2003, 48 (03) :257-293
[2]   NATURAL COURSE OF CHOROIDAL NEOVASCULAR MEMBRANES WITHIN THE FOVEAL AVASCULAR ZONE IN SENILE MACULAR DEGENERATION [J].
BRESSLER, SB ;
BRESSLER, NM ;
FINE, SL ;
HILLIS, A ;
MURPHY, RP ;
OLK, RJ ;
PATZ, A .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1982, 93 (02) :157-163
[3]   Quality of life associated with visual loss - A time tradeoff utility analysis comparison with medical health states [J].
Brown, MM ;
Brown, GC ;
Sharma, S ;
Busbee, B .
OPHTHALMOLOGY, 2003, 110 (06) :1076-1081
[4]   Impact of bilateral visual impairment on health-related quality of life: the Blue Mountains Eye Study [J].
Chia, EM ;
Wang, JJ ;
Rochtchina, E ;
Smith, W ;
Cumming, RR ;
Mitchell, P .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (01) :71-76
[5]   Higher risk of multiple falls among elderly women who lose visual acuity [J].
Coleman, AL ;
Stone, K ;
Ewing, SK ;
Nevitt, M ;
Cummings, S ;
Cauley, JA ;
Ensrud, KE ;
Harris, EL ;
Hochberg, MC ;
Mangione, CM .
OPHTHALMOLOGY, 2004, 111 (05) :857-862
[6]   Population-based assessment of childhood blindness in southern India [J].
Dandona, L ;
Williams, JD ;
Williams, BC ;
Rao, GN .
ARCHIVES OF OPHTHALMOLOGY, 1998, 116 (04) :545-546
[7]   The prevalence of eye disease in nursing home and non-nursing home geriatric populations [J].
Eichenbaum, JW ;
Burton, WB ;
Eichenbaum, GM ;
Mulvihill, M .
ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1999, 28 (03) :191-204
[8]   The impact of age-related macular degeneration on health status utility values [J].
Espallargues, M ;
Czoski-Murray, CJ ;
Bansback, NJ ;
Carlton, J ;
Lewis, GM ;
Hughes, LA ;
Brand, CS ;
Brazier, JE .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (11) :4016-4023
[9]  
FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640
[10]  
Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564